°ÇÃà ¼Ò½Ä

Á¦¸ñ [°ÇÃà»ç½Å¹®]±¹ÅäºÎ, ÀÚÀ²ÁÖÅÃÁ¤ºñ»ç¾÷¿¡ ¹Î°£Àü¹®°¡ Âü¿© È°¼ºÈ­ Áö¿ø
ÀÛ¼ºÀÏÀÚ 2020-04-27
¡ã ÀÚ·á=±¹Åä±³ÅëºÎ

±¹Åä±³ÅëºÎ´Â µµ½ÃÀç»ý ´ºµô»ç¾÷Áö ³» ³ëÈÄ ÀúÃþ ÁÖ°ÅÁö¿¡¼­ ÀÚÀ²ÁÖÅÃÁ¤ºñ»ç¾÷À» È°¼ºÈ­Çϱâ À§ÇÑ °ø°øÁö¿øÀ» °­È­ÇÑ´Ù°í 4¿ù 22ÀÏ ¹àÇû´Ù. Àü¹®¼ºÀÌ ºÎÁ·ÇÑ ÁÖ¹ÎÀ» À§ÇØ LH°¡ °ø°ø½ÃÇàÀÚ·Î Âü¿©ÇÏ°í, LH°¡ Âü¿©ÇÏÁö ¾Ê´Â »ç¾÷¿¡µµ Áö¿øÀ» °­È­ÇØ °ÇÃà»ç µî ¹Î°£ Àü¹®°¡ÀÇ Âü¿© È°¼ºÈ­¸¦ Áö¿øÇϱâ·Î Çß´Ù.

ÀÚÀ²ÁÖÅÃÁ¤ºñ»ç¾÷Àº 10È£ ¹Ì¸¸ÀÇ ´Üµ¶ ¶Ç´Â 20¼¼´ë ¹Ì¸¸ÀÇ ´Ù¼¼´ëÁÖÅà ÁýÁÖÀÎ 2¸í ÀÌ»óÀÌ ¸ð¿© ÁÖ¹ÎÇÕÀÇü¸¦ ±¸¼ºÇØ °øµ¿ÁÖÅÃÀ» ½ÅÃàÇÏ´Â ¼Ò´ÜÀ§ ÇÊÁö »ç¾÷À¸·Î, µµ½ÃÀç»ý Áö¿ª ³» Áְź¹Áö °³¼±À» À§ÇÑ ÇÙ½É ´ÜÀ§ »ç¾÷ÀÌ´Ù. ±×·¯³ª ³«ÈÄÇÑ µµ½ÃÀç»ý ´ºµô»ç¾÷ Áö¿ª Ư¼º»ó ¼öÀͼº È®º¸°¡ ¾î·Æ°í, »ç¾÷ ÀÎÁöµµ°¡ ³·°í ÁֹεéÀÇ Àü¹®¼ºÀÌ ºÎÁ·ÇØ È°¼ºÈ­¿¡ ¾î·Á¿òÀ» °Þ¾î¿Ô´Ù.

ÀÌ¿¡ ±¹ÅäºÎ¿Í Çѱ¹°¨Á¤¿ø, Çѱ¹ÅäÁöÁÖÅðø»ç(LH)´Â µµ½ÃÀç»ý ´ºµô»ç¾÷Áö ³»¿¡¼­ ÀÚÀ²ÁÖÅÃÁ¤ºñ»ç¾÷ ÃßÁøÀ» Èñ¸ÁÇÏ´Â ÁýÁÖÀο¡°Ô Áö¿øÀ» °­È­Çϱâ·Î Çß´Ù.

¸ÕÀú »ç¾÷¼º ºÐ¼®¿¡ ¼Ò¿äµÇ´Â ¼³°è ºñ¿ëÀ» Àü¾× Áö¿øÇØ Ãʱ⠺δãÀ» ´ëÆø °æ°¨ÇÑ´Ù. Âü¿©¸¦ Èñ¸ÁÇÏ´Â ÁÖ¹ÎÀº ÁöÀÚü³ª °¨Á¤¿øÀ» ÅëÇØ »ç¾÷¼º ºÐ¼®À» ½ÅûÇÒ ¼ö ÀÖ´Ù. ½Åû ¸ðÁýÀº ¼ö½Ã·Î ÁøÇàµÈ´Ù. ±¹ÅäºÎ´Â ´ëÇÑ°ÇÃà»çÇùȸ Ãßõ°ÇÃà»ç¿Í ÀÚÀ²ÁÖÅÃÁ¤ºñ»ç¾÷¿¡ Âü¿© °æÇèÀÌ ÀÖ´Â °ÇÃà»ç µî¿¡ ÀÚÀ²ÁÖÅÃÁ¤ºñ»ç¾÷ Ãʱ⠼³°è¸¦ À§Å¹ÇÏ°Ú´Ù´Â ¹æħÀÌ´Ù. ±¹ÅäºÎ´Â LH Âü¿© »ç¾÷Áö ¹ß±¼À» À§ÇØ ¿À´Â 6¿ù ¡®LH Âü¿© ÀÚÀ²ÁÖÅÃÁ¤ºñ »ç¾÷ °ø¸ð¡¯¸¦ ÁøÇàÇÑ´Ù°í ¹àÇû´Ù.

¶Ç °ÇÃà °æÇè°ú Àü¹®¼ºÀÌ ºÎÁ·ÇÑ ÁÖ¹ÎÀ» À§ÇØ LH°¡ °ø°ø½ÃÇàÀÚ·Î »ç¾÷¿¡ Âü¿©ÇÑ´Ù. LH°¡ ÁÖ¹ÎÇÕÀÇü¿Í °øµ¿½ÃÇà¾àÁ¤À» ü°áÇÏ°í, ÃÑ°ý»ç¾÷°ü¸®ÀÚ·Î Âü¿©ÇÏ´Â ÁÖ¹Î-LH °øµ¿»ç¾÷½ÃÇà¹æ½ÄÀ» ÃßÁøÇÑ´Ù. LH°¡ Âü¿©ÇØ °ø°øÀÓ´ëÁÖÅÃÀ» 20% ÀÌ»ó °ø±ÞÇÏ°Ô µÇ¸é ÁÖÅõµ½Ã±â±ÝÀ¸·Î ÃÑ »ç¾÷ºñÀÇ ÃÖ´ë 90%±îÁö ¿¬ÀÌÀ² 1.2%ÀÇ À¶ÀÚ¸¦ ¹ÞÀ» ¼ö ÀÖ´Ù. °ø»ç±â°£ Áß ¿øÁֹο¡°Ô Àα٠LH ÀÓ´ëÁÖÅÃÀ» ÀӽðÅÁֽü³·Î °ø±ÞÇØ ÁְźҾÈÀ» ´ú°í, °ø°øÂü¿©·Î Åõ¸í¼º ÀÖ´Â »ç¾÷ ÃßÁø°ú ÀûÁ¤ ¼öÁØÀÇ ÁÖ°Å Ç°ÁúÀ» È®º¸ÇÏ°Ú´Ù´Â ¹æħÀÌ´Ù.

¡ß °ÇÃà»ç µî ¹Î°£ Àü¹®°¡¿¡
   »ç¾÷¼º ºÐ¼®°á°ú µî Á¦°øÇÏ°í
   »ç¾÷È­ ½Ã °¢Á¾ ÇýÅà ºÎ¿©

°ø°ø½ÃÇàÀÚ°¡ Âü¿©ÇÏÁö ¾Ê´Â »ç¾÷¿¡ Áö¿øÀ» °­È­ÇØ °ÇÃà»ç, ½Ã°ø¾÷ü µî ¹Î°£ Àü¹®°¡ÀÇ Âü¿©¸¦ È°¼ºÈ­ÇÏ´Â ¹æ¾Èµµ ÃßÁøÇÑ´Ù. ÁÖ¹ÎÀÌ µ¿ÀÇÇÏ´Â °æ¿ì »ç¾÷Áö ³» ÀÚÀ²ÁÖÅÃÁ¤ºñ»ç¾÷ °èȹ°ú Ãʱ⠻ç¾÷¼º ºÐ¼® °á°ú¸¦ »ç¾÷ Âü¿©¸¦ Èñ¸ÁÇÏ´Â ¹Î°£ Àü¹®°¡¿¡°Ô Á¦°øÇÏ°í, À̸¦ »ç¾÷È­ÇÒ °æ¿ì Çѱ¹°¨Á¤¿ø ÅëÇÕ¼¾ÅÍ¿¡¼­ »ç¾÷À» Á¦¾ÈÇÏ´Â ¹Î°£ Àü¹®°¡µé¿¡ ¼³°è¡¤½Ã°øÀÌ ¿ì¼±µÉ ¼ö ÀÖµµ·Ï ÁֹΡ¤ÁöÀÚü¿ÍÀÇ ÇùÀÇ ¹× ÀΡ¤Çã°¡ ÁöÀûÁ¤¸® µî °¢Á¾ ÇàÁ¤ÀýÂ÷¸¦ Áö¿øÇÑ´Ù. LH´Â ´ºµô»ç¾÷Áö ³» ÀÚÀ²ÁÖÅûç¾÷ÀÇ ÀÏ¹Ý ºÐ¾çºÐÀ» ¿ì¼± ¸ÅÀÔ Áö¿øÇÏ´Â µî ¹Î°£ Àü¹®°¡¿¡ °¢Á¾ ÇýÅÃÀ» ºÎ¿©ÇÑ´Ù.

±¹ÅäºÎ´Â 4¿ù 27ÀϺÎÅÍ 2ÁÖ°£ ½Ã¡¤µµº° ¼³¸íȸ¸¦ °³ÃÖÇÏ°í, ÁöÀÚü³ª ÁÖ¹ÎÀÇ ¿äûÀÌ ÀÖ´Â °æ¿ì 1:1 ¼³¸íȸ¸¦ °³ÃÖÇØ ±¸Ã¼ÀûÀÎ Áö¿ø Á¦µµ¸¦ ¾È³»ÇÒ °èȹÀÌ´Ù. ¶Ç »ç¾÷ Âü¿©¸¦ Èñ¸ÁÇÏ´Â °ÇÃà»ç, ½Ã°ø¾÷ü µîÀÇ ¿äû¿¡´Â º¸´Ù ½ÉÈ­µÈ ¸ÂÃãÇü ¼³¸íȸ¸¦ Áö¿øÇÒ °ÍÀ̶ó°í ¹àÇû´Ù.

»ç¾÷°ú °ü·ÃµÈ ÀÚ¼¼ÇÑ »çÇ×Àº Çѱ¹°¨Á¤¿ø ȨÆäÀÌÁö(www.kab.co.kr)¸¦ Âü°íÇϰųª ÅëÇÕÁö¿ø¼¾ÅÍ(¼­¿ï 02-2187-4178, ´ë±¸ 053-663-8585)·Î ¹®ÀÇÇÏ¸é µÈ´Ù.



Ãâó : http://www.ancnews.kr/news/articleView.html?idxno=9620

À̸§ ºñ¹Ð¹øÈ£



* ÇÑ±Û 1000ÀÚ ±îÁö¸¸ ÀԷ°¡´É : ÀÚ
Unsummogs Cost effectiveness of afatinib, gefitinib, erlotinib and pemetrexed based chemotherapy as first line treatments for advanced non small cell lung cancer in China <a href=http://clomid.mom/>clomid by avents</a> Noncompliance with tamoxifen was associated with an 87 survival, compared with 96 for compliant women 2022-11-20 04:11:46
Dredymn Eduardo DWSxXypgSIPtjIjku 5 29 2022 <a href=https://nolvadex.mom>buy nolvadex for lab rats</a> 2022-12-17 19:24:48
neigree If this rumor turns out to be true that is a bad look especially given the explanation that was circulated recently <a href=https://lasix.buzz>lasix diuretic side effects</a> 2023-01-26 20:44:01
Bluetry Looking for work reglan 10 mg tablete The papers contained obvious flaws, such as claiming to have demonstrated a dose response relationship when the data reflected nothing of the sort <a href=https://stromectol.one>what is stromectol made from</a> Selective Estrogen Receptor Modulator; Progonadotropin Active Ingredient Clomiphene Citrate Concentration 50 mg pill Price For 50 pills Brand Ice Pharmaceuticals 2023-02-04 17:46:53
Bluetry ¬¤ Lenny syxOZFHhEy 6 28 2022 <a href=http://cialis.boats>cialis 20mg price</a> 2023-02-06 08:50:53

>ÀÌ¿ë¾à°ü >°³ÀÎÁ¤º¸ Ãë±Þ¹æħ >¿À½Ã´Â ±æ >°ü¸®ÀÚ


  • »óÈ£ °Ç¿µÁ¾ÇÕ°³¹ß¢ß´ëÇ¥ÀÚ ±è¿µÈ£»ó´ã¹®ÀÇ 02-3437-6733À̸ÞÀÏÁÖ¼Ò kunyoung09@naver.com
  • ÁÖ¼Ò ¼­¿ï½Ã ¼ÛÆı¸ ¼ÛÆÄ´ë·Î167, Bµ¿ 3Ãþ 318È£ (¹®Á¤µ¿, ¹®Á¤¿ªÅ׶óŸ¿ö) »ç¾÷ÀÚµî·Ï¹øÈ£ 290-88-00805 (»ç¾÷ÀÚÁ¤º¸È®ÀÎ)
  • ÀνºÅ¸±×·¥
  • COPYRIGHT¨Ï KUNYOUNG Construction Corp. All Rights Reserved